Your browser doesn't support javascript.
loading
Neutralization against Omicron sublineages (BA.2/BA.5/BQ.1.1/XBB/XBB.1.5) in bivalent BNT162b2-vaccinated HCWs with or without risk factors, or following BT infection with Omicron.
Amano, Masayuki; Otsu, Sachiko; Uemura, Yukari; Ichikawa, Yasuko; Matsumoto, Shota; Higashi-Kuwata, Nobuyo; Matsushita, Shuzo; Shimada, Shinya; Mitsuya, Hiroaki.
Afiliación
  • Amano M; Department of Clinical Retrovirology, Joint Research Center for Human Retrovirus Infection, Kumamoto University, 2-2-1 Honjo, Cyuou-ku, Kumamoto, 860-0811, Japan. mamano@kumamoto-u.ac.jp.
  • Otsu S; Department of Clinical Retrovirology, Joint Research Center for Human Retrovirus Infection, Kumamoto University, 2-2-1 Honjo, Cyuou-ku, Kumamoto, 860-0811, Japan.
  • Uemura Y; Department of Data Sciences, Center for Clinical Sciences, National Center for Global Health and Medicine (NCGM), Tokyo, Japan.
  • Ichikawa Y; Kumamoto General Hospital, Japan Community Healthcare Organization (JCHO), Kumamoto, Japan.
  • Matsumoto S; Kumamoto General Hospital, Japan Community Healthcare Organization (JCHO), Kumamoto, Japan.
  • Higashi-Kuwata N; Department of Refractory Viral Diseases, NCGM Research Institute, Tokyo, Japan.
  • Matsushita S; Department of Clinical Retrovirology, Joint Research Center for Human Retrovirus Infection, Kumamoto University, 2-2-1 Honjo, Cyuou-ku, Kumamoto, 860-0811, Japan.
  • Shimada S; Kumamoto General Hospital, Japan Community Healthcare Organization (JCHO), Kumamoto, Japan.
  • Mitsuya H; Department of Refractory Viral Diseases, NCGM Research Institute, Tokyo, Japan.
Sci Rep ; 13(1): 17404, 2023 10 13.
Article en En | MEDLINE | ID: mdl-37833390

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacuna BNT162 / Infección Irruptiva Límite: Humans Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacuna BNT162 / Infección Irruptiva Límite: Humans Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido